Citation: Rg. Sheiman, HIGH-RESOLUTION ULTRASONOGRAPHY FOR THE MANAGEMENT OF SEVERE ULCERATIVE-COLITIS - PATIENT FRIENDLY BUT NOT USER-FRIENDLY, Inflammatory bowel diseases, 3(4), 1997, pp. 321-322
Citation: Jh. Cho et al., CONFIRMATION OF A SUSCEPTIBILITY LOCUS FOR CROHNS-DISEASE ON CHROMOSOME-16, Inflammatory bowel diseases, 3(3), 1997, pp. 186-190
Authors:
VIDELA S
VILASECA J
GUARNER F
SALAS A
GONZALEZ G
ANTOLIN M
MALAGELADA JR
Citation: S. Videla et al., STIMULATION OF MUCOSAL INFLAMMATORY ACTIVITY BY THE NORMAL FECAL FLORA IN A RAT MODEL OF COLITIS, Inflammatory bowel diseases, 3(3), 1997, pp. 191-197
Citation: Ac. Blackburn et al., COLONIC ANTIOXIDANT STATUS IN DEXTRAN SULFATE-INDUCED COLITIS IN MICE, Inflammatory bowel diseases, 3(3), 1997, pp. 198-203
Citation: S. Schreiber et S. Wedel, DIAGNOSIS AND TREATMENT OF ANEMIA IN INFLAMMATORY BOWEL-DISEASE, Inflammatory bowel diseases, 3(3), 1997, pp. 204-216
Citation: Rs. Mcleod, THE PELVIC POUCH PROCEDURE REMAINS AN EXCELLENT OPTION FOR MOST PATIENTS WITH ULCERATIVE-COLITIS REQUIRING SURGERY, Inflammatory bowel diseases, 3(3), 1997, pp. 236-238
Citation: Wj. Sandborn, DOES THE SURGICAL FAILURE RATE, INCREASED INCIDENCE OF POUCHITIS, ANDRECENT FINDINGS OF DYSPLASIA IN POUCHES DETER YOU FROM RECOMMENDING AN ILEAL POUCH-ANAL ANASTOMOSIS FOR ULCERATIVE-COLITIS, Inflammatory bowel diseases, 3(3), 1997, pp. 239-240
Citation: Dh. Present et Pa. Banks, ILEAL POUCH-ANAL ANASTOMOSIS FOR ULCERATIVE-COLITIS - YES, NO, OR MAYBE, Inflammatory bowel diseases, 3(3), 1997, pp. 241-242
Citation: L. Mayer, WHAT DO MALARIA, RHEUMATOID-ARTHRITIS, SYSTEMIC LUPUS-ERYTHEMATOSUS AND ULCERATIVE-COLITIS HAVE IN COMMON, Inflammatory bowel diseases, 3(3), 1997, pp. 244-245
Citation: Lr. Sutherland et al., ALTERNATIVES TO SULFASALAZINE - A METAANALYSIS OF 5-ASA IN THE TREATMENT OF ULCERATIVE-COLITIS, Inflammatory bowel diseases, 3(2), 1997, pp. 65-78
Authors:
WEINSTEIN T
VALDERRAMA E
PETTEI M
LEVINE J
Citation: T. Weinstein et al., ESOPHAGEAL CROHNS-DISEASE - MEDICAL-MANAGEMENT AND CORRELATION BETWEEN CLINICAL, ENDOSCOPIC, AND HISTOLOGIC FEATURES, Inflammatory bowel diseases, 3(2), 1997, pp. 79-83
Citation: S. Urayama et Eb. Chang, MECHANISMS AND TREATMENT OF DIARRHEA IN INFLAMMATORY BOWEL DISEASES, Inflammatory bowel diseases, 3(2), 1997, pp. 114-131
Citation: Rp. Macdermott et R. Burakoff, IMMUNE NON-IMMUNE CELL-INTERACTIONS IN INTESTINAL INFLAMMATION WORKSHOP/, Inflammatory bowel diseases, 3(2), 1997, pp. 132-132